55 related articles for article (PubMed ID: 21284956)
1. Integrity characterization of myoglobin released from poly(ε-caprolactone) microspheres using two analytical methods: UV/Vis spectrometry and conductometric bi-enzymatic biosensor.
Hnaien M; Ruffin E; Bordes C; Marcillat O; Lagarde F; Jaffrezic-Renault N; Briançon S
Eur J Pharm Biopharm; 2011 Jun; 78(2):298-305. PubMed ID: 21284956
[TBL] [Abstract][Full Text] [Related]
2. The microencapsulation of protein using a novel ternary blend based on poly(epsilon-caprolactone).
Huatan H; Collett JH; Attwood D
J Microencapsul; 1995; 12(5):557-67. PubMed ID: 8544099
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agent.
Zhang Y; Zhang Y; Guo S; Huang W
Int J Pharm; 2009 Mar; 369(1-2):19-23. PubMed ID: 19041382
[TBL] [Abstract][Full Text] [Related]
4. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
5. Cellulose acetate butyrate and polycaprolactone for ketoprofen spray-dried microsphere preparation.
Giunchedi P; Conti B; Maggi L; Conte U
J Microencapsul; 1994; 11(4):381-93. PubMed ID: 7931938
[TBL] [Abstract][Full Text] [Related]
6. Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers.
Zhao J; Liu CS; Yuan Y; Tao XY; Shan XQ; Sheng Y; Wu F
Biomaterials; 2007 Mar; 28(7):1414-22. PubMed ID: 17126898
[TBL] [Abstract][Full Text] [Related]
7. Determination of poly(epsilon-caprolactone) solubility parameters: application to solvent substitution in a microencapsulation process.
Bordes C; Fréville V; Ruffin E; Marote P; Gauvrit JY; Briançon S; Lantéri P
Int J Pharm; 2010 Jan; 383(1-2):236-43. PubMed ID: 19781605
[TBL] [Abstract][Full Text] [Related]
8. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
[TBL] [Abstract][Full Text] [Related]
9. Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: development, characterization and in vitro evaluation of their antitumoral efficacy.
Hernán Pérez de la Ossa D; Ligresti A; Gil-Alegre ME; Aberturas MR; Molpeceres J; Di Marzo V; Torres Suárez AI
J Control Release; 2012 Aug; 161(3):927-32. PubMed ID: 22580111
[TBL] [Abstract][Full Text] [Related]
10. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z
Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable microspheres containing poly(epsilon-caprolactone)-Pluronic block copolymers for temperature-responsive release of proteins.
Lee JI; Yoo HS
Colloids Surf B Biointerfaces; 2008 Jan; 61(1):81-7. PubMed ID: 17764912
[TBL] [Abstract][Full Text] [Related]
13. Improvement of a bovine serum albumin microencapsulation process by screening design.
Al Haushey L; Bolzinger MA; Bordes C; Gauvrit JY; Briançon S
Int J Pharm; 2007 Nov; 344(1-2):16-25. PubMed ID: 17651928
[TBL] [Abstract][Full Text] [Related]
14. Characterization of conformational changes and noncovalent complexes of myoglobin by electrospray ionization mass spectrometry, circular dichroism and fluorescence spectroscopy.
Lin X; Zhao W; Wang X
J Mass Spectrom; 2010 Jun; 45(6):618-26. PubMed ID: 20527030
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen peroxide biosensor based on a myoglobin/hydrophilic room temperature ionic liquid film.
Safavi A; Farjami F
Anal Biochem; 2010 Jul; 402(1):20-5. PubMed ID: 20230770
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vitro drug release of poly-epsilon-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres.
Guzman M; Molpeceres J; Garcia F; Aberturas MR
J Microencapsul; 1996; 13(1):25-39. PubMed ID: 8903783
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading.
Aliabadi HM; Elhasi S; Mahmud A; Gulamhusein R; Mahdipoor P; Lavasanifar A
Int J Pharm; 2007 Feb; 329(1-2):158-65. PubMed ID: 17008034
[TBL] [Abstract][Full Text] [Related]
18. Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.
Karataş A; Sonakin O; Kiliçarslan M; Baykara T
J Microencapsul; 2009 Feb; 26(1):63-74. PubMed ID: 18608798
[TBL] [Abstract][Full Text] [Related]
19. Release behaviors of porous poly(butylene succinate)/poly(epsilon-caprolactone) microcapsules containing indomethacin.
Park SJ; Lee YM; Hong SK
Colloids Surf B Biointerfaces; 2006 Feb; 47(2):211-5. PubMed ID: 16413177
[TBL] [Abstract][Full Text] [Related]
20. Surface property and in vitro biodegradation of microspheres fabricated by poly(epsilon-caprolactone-b-ethylene oxide) diblock copolymers.
Yu G; Zhang Y; Shi X; Li Z; Gan Z
J Biomed Mater Res A; 2008 Mar; 84(4):926-39. PubMed ID: 17647229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
